1. De‐escalation or discontinuation of tyrosine kinase inhibitor in patients with chronic myeloid leukemia: A multicentral, open‐label, prospective trial in China. Issue 4 (19th September 2022) Authors: Luo, Jie; Du, Xin; Lou, Jin; Wu, Jianwei; Ma, Liping; Huang, Jixian; Wang, Liangtuo; Tu, Chuanqing; Liu, Zelin; Chen, Liya; Tan, Yaxian; Luo, Dongmei; Liang, Hanyin; Yin, Changxin; Cao, Rui; Zhou, Xuan; Liu, Qifa; Liu, Xiaoli; Xu, Na Journal: EJHaem Issue: Volume 3:Issue 4(2022) Page Start: 1220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗